Paracel Explorer

Dernière publication·Octobre 2026

Sevikar

Amlodipinum / Olmesartani medoxomilum — cpr pell 40/5mg

Daiichi Sankyo (Schweiz) AG

Swissmedic58778

Dossier18889

Statut

Original

GénériquesOlmesartan Amlodipin Zentiva, Olmesartan-Amlodipin-Mepha, Olmésartan Amlo Spirig HC, Olmésartan Amlodipin Sandoz

Remboursement

QP 10%

Modifications (18)